Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Holmium-166-DOTMP with Melphalan and PBSC for Multiple Myeloma
NCT00004158Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jun 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Holmium-166-DOTMP in multiple myeloma (MM), sponsored by Fred Hutchinson Cancer Center. Started Jun 1999; status: completed.
02
Drugs
Holmium-166-DOTMP
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00004158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004158.